Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Julie Carter
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Living Beings
Concepts & Ideas
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
31
Nutt, John
8
Hammerstad, John
5
Archbold, Patricia
5
Stewart, Barbara
4
Lyons, Karen
3
Goetz, Christopher
3
Goy, Elizabeth
3
Ganzini, Linda
3
Woodward, WR
2
Thalamas, Claire
2
Rascol, Olivier
2
Rehemtulla, Alnawaz
2
Olanow, Warren
2
Pietronigro, Dennis
2
Ross, Brian
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Julie Carter (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lyons Karen S; Stewart Barbara J; Archbold Patricia G; Carter Julie H
Optimism, pessimism, mutuality, and gender: predicting 10-year role strain in Parkinson's disease spouses.
The Gerontologist 2009;49(3):378-87.
-
2008: Carter Julie H; Stewart Barbara J; Lyons Karen S; Archbold Patricia G
Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression?
Movement disorders : official journal of the Movement Disorder Society 2008;23(9):1211-6.
-
2008: Goy Elizabeth Ruth; Carter Julie; Ganzini Linda
Neurologic disease at the end of life: caregiver descriptions of Parkinson disease and amyotrophic lateral sclerosis.
Journal of palliative medicine 2008;11(4):548-54.
-
2008: Goy Elizabeth R; Carter Julie H; Ganzini Linda
Needs and experiences of caregivers for family members dying with Parkinson disease.
Journal of palliative care 2008;24(2):69-75.
-
2007: Goy Elizabeth R; Carter Julie H; Ganzini Linda
Parkinson disease at the end of life: caregiver perspectives.
Neurology 2007;69(6):611-2.
-
2007: Nutt John G; Carter Julie H; Carlson Nichole E
Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
Archives of neurology 2007;64(3):319-23.
-
2005: Dowling Glenna A; Mastick Judith; Colling Eric; Carter Julie H; Singer Clifford M; Aminoff Michael J
Melatonin for sleep disturbances in Parkinson's disease.
Sleep medicine 2005;6(5):459-66.
-
2005: Hamstra Daniel A; Moffat Bradford A; Hall Daniel E; Young John M; Desmond Timothy J; Carter Julie; Pietronigro Dennis; Frey Kirk A; Rehemtulla Alnawaz; Ross Brian D
Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study.
Journal of neuro-oncology 2005;73(3):225-38.
-
2004: Hall Daniel E; Moffat Bradford A; Stojanovska Jadranka; Johnson Timothy D; Li Zhuolin; Hamstra Daniel A; Rehemtulla Alnawaz; Chenevert Thomas L; Carter Julie; Pietronigro Dennis; Ross Brian D
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7852-9.
-
2004: Lyons Karen S; Stewart Barbara J; Archbold Patricia G; Carter Julie H; Perrin Nancy A
Pessimism and optimism as early warning signs for compromised health for caregivers of patients with Parkinson's disease.
Nursing research 2004;53(6):354-62.
-
2004: Nutt John G; Carter Julie H; Sexton Gary J
The dopamine transporter: importance in Parkinson's disease.
Annals of neurology 2004;55(6):766-73.
-
2004: Lyons Karen S; Carter Julie H; Carter Emily H; Rush Kirsten N; Stewart Barbara J; Archbold Patricia G
Locating and retaining research participants for follow-up studies.
Research in nursing & health 2004;27(1):63-8.
-
2002: Shults Clifford W; Oakes David; Kieburtz Karl; Beal M Flint; Haas Richard; Plumb Sandy; Juncos Jorge L; Nutt John; Shoulson Ira; Carter Julie; Kompoliti Katie; Perlmutter Joel S; Reich Stephen; Stern Matthew; Watts Ray L; Kurlan Roger; Molho Eric; Harrison Madaline; Lew Mark;
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Archives of neurology 2002;59(10):1541-50.
-
2002: Nutt John G; Carter Julie H; Lea Eric S; Sexton Gary J
Evolution of the response to levodopa during the first 4 years of therapy.
Annals of neurology 2002;51(6):686-93.
-
2002: Esiri M M; Carter J; Ironside J W
Macrophage and microglial cell immunoreactivity for PrP(c) in a random post-mortem population.
Neuropathology and applied neurobiology 2002;28(1):79-82.
-
2001: Carter J; Lippa C F
Beta-amyloid, neuronal death and Alzheimer's disease.
Current molecular medicine 2001;1(6):733-7.
-
2001: Nutt J G; Rufener S L; Carter J H; Anderson V C; Pahwa R; Hammerstad J P; Burchiel K J
Interactions between deep brain stimulation and levodopa in Parkinson's disease.
Neurology 2001;57(10):1835-42.
-
2001: Rascol O; Nutt J G; Blin O; Goetz C G; Trugman J M; Soubrouillard C; Carter J H; Currie L J; Fabre N; Thalamas C; Giardina W W; Wright S
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
Archives of neurology 2001;58(2):249-54.
-
2000: Nutt J G; Carter J H
Apomorphine can sustain the long-duration response to L-DOPA in fluctuating PD.
Neurology 2000;54(1):247-50.
-
1999: Rascol O; Blin O; Thalamas C; Descombes S; Soubrouillard C; Azulay P; Fabre N; Viallet F; Lafnitzegger K; Wright S; Carter J H; Nutt J G
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.
Annals of neurology 1999;45(6):736-41.
-
1998: Carter J H; Nutt J G
Family caregiving: a neglected and hidden part of health care delivery.
Neurology 1998;51(5):1245-6.
-
1998: Thulin P C; Woodward W R; Carter J H; Nutt J G
Levodopa in human breast milk: clinical implications.
Neurology 1998;50(6):1920-1.
-
1998: Maricle R A; Valentine R J; Carter J; Nutt J G
Mood response to levodopa infusion in early Parkinson's disease.
Neurology 1998;50(6):1890-2.
-
1998: Carter J H; Stewart B J; Archbold P G; Inoue I; Jaglin J; Lannon M; Rost-Ruffner E; Tennis M; McDermott M P; Amyot D; Barter R; Cornelius L; Demong C; Dobson J; Duff J; Erickson J; Gardiner N; Gauger L; Gray P; Kanigan B; Kiryluk B; Lewis P; Mistura K; Malapira T; Zoog K
Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):20-8.
-
1997: Nutt J G; Carter J H; Van Houten L; Woodward W R
Short- and long-duration responses to levodopa during the first year of levodopa therapy.
Annals of neurology 1997;42(3):349-55.
-
1997: Nutt J G; Carter J H; Lea E S; Woodward W R
Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):285-92.
-
1995: Maricle R A; Nutt J G; Valentine R J; Carter J H
Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.
Neurology 1995;45(9):1757-60.
-
1995: Nutt J G; Carter J H; Woodward W R
Long-duration response to levodopa.
Neurology 1995;45(8):1613-6.
-
1995: McDermott M P; Jankovic J; Carter J; Fahn S; Gauthier S; Goetz C G; Golbe L I; Koller W; Lang A E; Olanow C W
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.
Archives of neurology 1995;52(6):565-70.
-
1995: Maricle R A; Nutt J G; Carter J H
Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):329-32.
-
1994: Kieburtz K; McDermott M; Como P; Growdon J; Brady J; Carter J; Huber S; Kanigan B; Landow E; Rudolph A
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group.
Neurology 1994;44(9):1756-9.
-
1994: Nutt J G; Carter J H; Woodward W R
Effect of brief levodopa holidays on the short-duration response to levodopa: evidence for tolerance to the antiparkinsonian effects.
Neurology 1994;44(9):1617-22.
-
1994: Nutt J G; Woodward W R; Beckner R M; Stone C K; Berggren K; Carter J H; Gancher S T; Hammerstad J P; Gordin A
Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.
Neurology 1994;44(5):913-9.
-
1993: Nutt J G; Carter J H; Woodward W; Hammerstad J P; Gancher S T
Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):139-43.
-
1992: Nutt J G; Woodward W R; Carter J H; Gancher S T
Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenon.
Archives of neurology 1992;49(11):1123-30.
-
1992: Carter J H; Nutt J G; Woodward W R
The effect of exercise on levodopa absorption.
Neurology 1992;42(10):2042-5.
-
1991: Carter J H
Tics through Tourette's syndrome.
The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 1991;23(3):145-7.
-
1990: Jankovic J; McDermott M; Carter J; Gauthier S; Goetz C; Golbe L; Huber S; Koller W; Olanow C; Shoulson I
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
Neurology 1990;40(10):1529-34.
-
1989: Nutt J G; Woodward W R; Carter J H; Trotman T L
Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa.
Journal of neurology, neurosurgery, and psychiatry 1989;52(4):481-7.
-
1989: Carter J H; Nutt J G; Woodward W R; Hatcher L F; Trotman T L
Amount and distribution of dietary protein affects clinical response to levodopa in Parkinson's disease.
Neurology 1989;39(4):552-6.
-
1988: Kurlan R; Nutt J G; Woodward W R; Rothfield K; Lichter D; Miller C; Carter J H; Shoulson I
Duodenal and gastric delivery of levodopa in parkinsonism.
Annals of neurology 1988;23(6):589-95.
-
1986: Nutt J G; Woodward W R; Carter J H
Clinical and biochemical studies with controlled-release levodopa/carbidopa.
Neurology 1986;36(9):1206-11.
-
1986: Hammerstad J P; Carter J; Nutt J G; Casten G C; Shrotriya R C; Alms D R; Temple D
Buspirone in Parkinson's disease.
Clinical neuropharmacology 1986;9(6):556-60.
-
1985: Nutt J G; Hammerstad J P; Carter J H; deGarmo P L
Lisuride treatment of focal dystonias.
Neurology 1985;35(8):1242-3.
-
1984: Nutt J G; Carter J H
Sensory symptoms in parkinsonism related to central dopaminergic function.
Lancet 1984;2(8400):456-7.
-
1984: Smith J A; Carter J H
Neuroleptic malignant syndrome with a positive Weil-Felix test.
The American journal of psychiatry 1984;141(4):609.
-
1984: Nutt J G; Woodward W R; Hammerstad J P; Carter J H; Anderson J L
The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.
The New England journal of medicine 1984;310(8):483-8.
-
1984: Nutt J G; Hammerstad J P; deGarmo P; Carter J
Cranial dystonia: double-blind crossover study of anticholinergics.
Neurology 1984;34(2):215-7.
-
1983: Nutt J G; Hammerstad J P; Carter J H; deGarmo P
Meige syndrome: treatment with trihexyphenidyl.
Advances in neurology 1983;37():201-5.
Sign-in to see more